Oral Medication | Page 11 of 11

Januvia (Sitagliptin) has been approved by the European Commission

According to Diabetes UK the European Commission has approved Sitagliptin ,known as Januvia, as an add-on to insulin (with or without metformin) for people with type 2 diabetes. Most type 2 diabetics can control their condition with a combination of diet, physical activity and conventional medication. Januvia was approved by the FDA in 2006...

Sirona Biochem Corp. Says New Results Show SGLT2 Sugar Blockers Could Help Fight Diabetes

In a press release dated November 17, Sirona Biochem Corp. announced that results of their latest clinical trials showed the SGLT2 inhibitor dapagliflozin lowered levels of HbA1c blood sugar significantly more than the placebo, and that it was safe and well tolerated with no serious treatment-related adverse events...

Takeda and Amylin to Co-develop Obesity Treatments

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company Limited announced an agreement to co-develop and commercialize pharmaceutical products for the treatment of obseity and related conditions. Amylin, whose top product, Byetta, had sales of $678.5 million last year. will receive a one-time up-front payment of $75 million from Takeda, the largest pharmaceutical

Merck’s Diabetes Drug Januvia Linked to Pancreatitis

The FDA announced yesterday that it has received 88 reports of pancreatitis (inflammation of the pancreas) in patients taking the drugs Januvia (or Janumet). Many of these patients required hospitalization and 53% of the cases resolved once the drug was discontinued....